[{"NetIncomeLoss_1_Q1_USD":12749000.0,"AociLossCashFlowHedgeCumulativeGainLossAfterTax_0_Q1_USD":-33000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":143395000.0,"DueFromRelatedPartiesCurrent_0_Q1_USD":1102000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":7104000.0,"LiabilitiesNoncurrent_0_Q1_USD":2943504000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":239501000.0,"InterestPaidNet_1_Q1_USD":29917000.0,"RoyaltyExpense_1_Q1_USD":3582000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-34361000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-12693000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-33885000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-56000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":574322000.0,"AssetsCurrent_0_Q1_USD":1559661000.0,"NotesPayableRelatedPartiesNoncurrent_0_Q1_USD":36828000.0,"LongTermDebtCurrent_0_Q1_USD":29817000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-1431000.0,"RestructuringCharges_1_Q1_USD":363000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":90726000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":301543000.0,"RepaymentsOfRelatedPartyDebt_1_Q1_USD":1000000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q1_USD":9000000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":1072138000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":676000.0,"DueToRelatedPartiesCurrent_0_Q1_USD":20100000.0,"IncomeTaxesPaidNet_1_Q1_USD":733000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":379395000.0,"GainLossRelatedToLitigationSettlement_1_Q1_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":7839000.0,"OtherAssetsNoncurrent_0_Q1_USD":19561000.0,"ProceedsFromIssuanceOfMediumTermNotes_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":399486000.0,"EarningsPerShareBasic_1_Q1_USD":0.05,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q1_USD":7302000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":155162000.0,"MinorityInterest_0_Q1_USD":43693000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-593000.0,"InventoryWriteDown_1_Q1_USD":16021000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":151220000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":794000.0,"AccountsReceivableNetCurrent_0_Q1_USD":530600000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":359000.0,"NumberOfReportableSegments_1_Q1_segment":3.0,"TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0_Q1_USD":13079000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-37226000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":1662440000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":2088000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":1970000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.024,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-26149000.0,"TemporaryEquityNetIncome_1_Q1_USD":1796000.0,"IncreaseDecreaseInInventories_1_Q1_USD":20283000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q1_USD":-2149000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":6706000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":13810000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":41672000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":452097000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":48182000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":51633000.0,"ShareBasedCompensation_1_Q1_USD":5330000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":136910000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":7104000.0,"Goodwill_0_Q1_USD":522758000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":14904000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":2102000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5330000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":148128000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":205874000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":148013000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q1_USD":0.0,"LiabilitiesCurrent_0_Q1_USD":636779000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":0.0,"NonoperatingIncomeExpense_1_Q1_USD":-31003000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":455814000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":75137000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":676000.0,"LongTermDebtNoncurrent_0_Q1_USD":2728212000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":1262954000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":-6366000.0,"GrossProfit_1_Q1_USD":191562000.0,"AdditionalPaidInCapital_0_Q1_USD":634484000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":0.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":366708000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":883559000.0,"InterestRateCashFlowHedgeLiabilityAtFairValue_0_Q1_USD":33131000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":471165000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":97937000.0,"Assets_0_Q1_USD":3960070000.0,"EarningsPerShareDiluted_1_Q1_USD":0.04,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-108385000.0,"DueToAffiliateNoncurrent_0_Q1_USD":2061000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-602000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":493105000.0,"OperatingIncomeLoss_1_Q1_USD":45907000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":20772000.0,"InventoryNet_0_Q1_USD":497008000.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":1283045000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":3960070000.0,"PreferredStockSharesAuthorized_0_Q1_shares":2000000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":125091000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":3717000.0,"ProfitLoss_1_Q1_USD":14545000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":63789000.0,"FinitelivedIntangibleAssetsAcquired1_1_Q1_USD":131000000.0,"GoodwillAcquiredDuringPeriod_1_Q1_USD":0.0,"StockholdersEquity_0_Q1_USD":323015000.0,"IncreaseDecreaseInDueToRelatedParties_1_Q1_USD":3260000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":11776000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":1444000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":2183000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-280115000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":108693000.0,"AssetImpairmentCharges_1_Q1_USD":0.0,"IncreaseDecreaseInDueFromRelatedParties_1_Q1_USD":-301000.0,"Ticker":"AMRX","CIK":"1723128","name":"AMNEAL PHARMACEUTICALS, INC.","OfficialName":"Amneal Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"632684518.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210507"}]